Addison's Disease
Allison M. Martin
<p>Allison M. Martin, MD, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics, Microbiology and Immunology at our Albert Einstein College of Medicine. Dr. Martin’s clinical focus centers on pediatric brain and spinal cord tumors.</p><p>After receiving her Bachelor of Arts in biology from Bryn Mawr College in 2001, Dr. Martin earned her Doctor of Medicine at Jefferson Medical College in 2007. She completed her pediatrics residency at the University of Pittsburgh in 2010, followed by a pediatric hematology/oncology fellowship at the Johns Hopkins University School of Medicine and the National Institutes of Health in 2013. Following this, Dr. Martin completed an additional fellowship in pediatric neuro-oncology at the Johns Hopkins University School of Medicine in 2014.</p><p>Dr. Martin’s research focuses on high-risk group 3 and refractory medulloblastoma. Her research program focuses on uncovering new ways to harness the immune system to treat this disease. Her work has been shared through numerous peer-reviewed publications, abstracts, case reports and invited talks and panels. She has also been principal investigator and co-investigator on several funded research projects and is a reviewer for <em>Cancers</em>.</p><p>Dr. Martin is board certified in Pediatrics and Pediatric Hematology-Oncology. She is a member of the Children’s Oncology Group (COG), the Cancer Therapy Evaluation Program (CTEP) and the Society of Immunotherapy and Cancer (SITC). In 2021, Dr. Martin received the Pediatric Hematology/Oncology Fellows Teaching Award from the Children’s Hospital at Montefiore Einstein. She was named a “Top Doctor” by Castle Connolly in 2024.</p>
Anjali Manavalan
Hanna Lee
Leslie S. Lam
<p>Pediatric Endocrinology</p>
Pediatric endocrinology and thyroidology
Pediatric diabetes, pediatric endocrinology, pediatric thyroidology
<p>As a pediatric endocrinologist, Dr. Lam manages and cares for children and adolescents in many areas of clinical endocrinology, including growth disorders, premature pubertal advancement or delay, diabetes, adrenal disorders, and calcium and vitamin D abnormalities, with particular interest in pediatric thyroid diseases and thyroid cancer. Besides his clinical work, Dr. Lam is actively involved in the teaching of pediatric house staff, fellows and medical students in both the hospital and the outpatient clinic settings.??? </p><p>As a clinical research scientist, Dr. Lam is actively engaged in research concerning the role of hormonal disorders in children. He has particular interest in thyroid diseases and thyroid cancer as they pertain to the pediatric population and is involved in several projects examining the methods by which thyroid diseases and thyroid cancer are generally evaluated and treated.</p>
Preeti Kishore
<p style="font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0pt 0pt .0001pt 0pt;"><span style="font-size: 10.0pt; font-family: Arial;">Dr. Preeti Kishore is a Professor in the Division of Endocrinology. </span><span style="font-family: Arial; font-size: 13.3333px;"> She is the site director for the Einstein/Montefiore Endocrinology Fellowship Program at Jacobi Medical Center. As Chief of the Endocrinology Division at Jacobi she is responsible for the clinical endocrine inpatient and outpatient operations at Jacobi and North Central Bronx Hospitals.</span><span style="font-family: Arial; font-size: 13.3333px;"> She actively participates in the teaching of endocrinology fellows, internal medicine residents and Einstein medical students. Her education philosophy is to empower learners to drive their own educational goals/learning. She is interested in the use of diabetes technology to manage low health literacy patients with diabetes. She is also the Director of the Weight Management Program at Jacobi.</span></p>
<p style="font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0pt 0pt .0001pt 0pt;"><span style="font-family: Arial; font-size: 10pt;">Her research interests have been in Type 2 Diabetes Mellitus and the Insulin resistance syndrome. She has investigated the pathogenic role of free fatty acids in various aspects of </span><span style="font-family: Arial; font-size: 13.3333px;">Type 2 Diabetes Mellitus</span><span style="font-family: Arial; font-size: 10pt;">, particularly the role they play in regulating “glucose effectiveness”. She is also interested in the role of adipose tissue inflammation in the pathogenesis of the metabolic syndrome and insulin resistance. As an extension to her interest in adipose inflammation, she has investigated the role of vitamin D deficiency in Type 2 diabetes and whether it may regulate adipose inflammation/fibrosis. </span></p>
<p style="font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0pt 0pt .0001pt 0pt;"><span style="font-family: Arial; font-size: 10pt;">Dr. Kishore is </span><span style="font-family: Arial; font-size: 13.3333px;">a member of the Leo M Davidoff Society and a</span><span style="font-family: Arial; font-size: 10pt;"> recipient of the prestigious Henry Christian Award of the American Federation of Medical Research. She is also the recipient of several teaching/advising awards. </span></p>
<p>Esterson YB, Carey M, Boucai L, Goyal A, Raghavan P, Zhang K, Mehta D, Feng D, Wu L, Kehlenbrink S, Koppaka S, Kishore P, Hawkins M.Central Regulation of Glucose Production May Be Impaired in Type 2 Diabetes. Diabetes. 2016 Sep;65(9):2569-79</p>
<p>Kishore P, Boucai L, Zhang K, Li W, Koppaka S, Kehlenbrink S, Schiwek A, Esterson YB, Mehta D, Bursheh S, Su Y, Gutierrez-Juarez R, Muzumdar R, Schwartz GJ, Hawkins M. Activation of K(ATP) channels suppresses glucose production in humans. J Clin Invest. 2011 Dec;121(12):4916-20</p>
<p>Kishore P, Li W, Tonelli J, Lee DE, Koppaka S, Zhang K, Lin Y, Kehlenbrink S, Scherer PE, Hawkins M. Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages. Sci Transl Med. 2010 Feb 24;2(20):20ra15.</p>
Tannaz Iranpour Boroujeni
Meredith A. Hawkins
<p>Dr. Meredith Hawkins is Professor of Medicine and Associate Director of the Einstein-Mt. Sinai Regional Diabetes Research Center. She holds the Harold and Muriel Block Chair in Medicine. Dr. Hawkins earned her M.D. degree <em>cum laude</em> from the University of Toronto and a Master of Science in Clinical Research Methods <em>cum laude</em> from the Albert Einstein College of Medicine. She has served as Associate Editor of the <em>American Journal of Physiology</em>, and as Secretary Treasurer of the American Federation of Medical Research. Dr. Hawkins' current research interests include the effects of nutrient deficiency and excess on the pathogenesis of diabetes mellitus, central regulation of glucose metabolism, nutritional regulation of adipose tissue inflammation, and hypoglycemia-associated autonomic failure.</p>
<p>Dr. Hawkins is a Beeson Scholar of the American Federation of Aging Research, and has received research grants from the National Institutes of Health (continually since 1999), the American Diabetes Association, the Juvenile Diabetes Foundation International and the Diabetes Action Foundation International. She is the recipient of numerous honors and awards, including the Junior Physician Scientist Award (2001) and the Outstanding Investigator Award (2012) from the American Federation of Medical Research, the Novartis Young Investigator award in Diabetes Research (2007), and election to the American Society for Clinical Investigation (2012). She recently served on the Congressionally-appointed National Clinical Care Commission. </p>
<p>Dr. Hawkins founded and directs Einstein's Global Diabetes Institute (<a href="/centers/global-health/global-diabetes-institute/">http://www.einstein.yu.edu/centers/global-health/global-diabetes-instit…;, with the goal of building strategic partnerships in medical research and education to combat the burgeoning global diabetes epidemic.</p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">Dr. Hawkins specializes in diabetes, with a particular emphasis on the dramatic rise of the disease worldwide. She has traveled the globe investigating diabetes since 1996 and is the founding director of the Global Diabetes Institute (GDI) at Einstein, which conducts diabetes education and training for healthcare workers in South and Central America, Eastern Europe, Africa and Asia.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">Dr. Hawkins also studies the role of nutrients and inflammation in the development of prediabetes and diabetes and is currently investigating the impact of vitamin D on the development and management of the disease.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">In collaboration with researchers in India, Dr. Hawkins is investigating malnutrition diabetes, a little understood form of the disease that particularly affects the developing world. Dr. Hawkins is one of the organizers of an annual international conference for continuing medical education that alternates between Asia and Africa. Under Dr. Hawkins’ leadership, the GDI has partnered with faculty at Uganda’s leading medical school to improve diabetes care in hospitals and clinics throughout the country. An NIH-funded researcher, Dr. Hawkins has received the Novartis Young Investigator in Diabetes and the Junior Physician Scientist Award of the American Federation of Medical Research.</span></p>
<p>Past 3 years:</p>
<ol>
<li><p>Wadivkar P, Thomas N, Jebasingh F, Bacot-Davis VR, Maini R, and Hawkins M. Undernutrition-Associated Diabetes Mellitus: Pathophysiology of a Global Problem. Physiology. 19 June 2025. doi: 10.1152/physiol.00065.2024.</p>
</li>
<li><p>Wadivkar P , Hawkins M. Is gestational diabetes mellitus in lean women a distinct entity warranting a modified management approach? Front. Clin. Diabetes Healthc., 06 May 2024.Sec. Diabetes and Pregnancy. doi: 10.3389/fcdhc.2024.1338597.</p></li>
<li>
<p>Carey M, Lontchi-Yimagou E, Mitchell W, Reda S, Zhang K, Kehlenbrink S, Koppaka S, Maginley SR, Aleksic S, Bhansali S, Huffman DM, Hawkins M. Central KATP channels modulate glucose effectiveness in humans and rodents. Diabetes. 2020 Jun;69(6):1140-1148. doi: 10.2337/db19-1256. PMID: 32217610 (Selected as Editor’s Choice by Science Translational Medicine, 29 Apr 2020: Vol. 12, Issue 541, eabb5677).</p>
</li>
<li>
<p>Lontchi-Yimagou E, Aleksic S, Hulkower R, Gospin R, Goyal A, Kuo B, Mitchell WG, You JY, Upadhyay L, Carey M, Sandu OA, Gabriely I, Shamoon H, Hawkins M. Plasma epinephrine contributes to the development of experimental hypoglycemic-associated autonomic failure. Journal of Clinical Endocrinology and Metabolism 2020 Nov 1;105(11):dgaa539. doi: 10.1210/clinem/dgaa539.PMID: 32915987</p>
</li>
<li>
<p>Lontchi-Yimagou E, Kang S, Goyal A, You J-Y, Carey M, Rosen E, Kishore P, Hawkins M. Insulin Sensitizing Effects of Vitamin D Mediated through Reduced Adipose Tissue Inflammation and Fibrosis in Humans and Mice. Molecular Metabolism 2020 Dec;42:101095. doi: 10.1016/j.molmet.2020.101095. Epub 2020 Oct 10. PMID: 33045433 </p>
</li>
<li>
<p>Brightwell CR, Kulkarni AS, Paredes W, Zhang K, Perkins JB, Gatlin KJ, Custodio M, Farooq H, Zaidi B, Pai R, Buttar RS, Tang Y, Melamed ML, Hostetter TH, Pessin JE, Hawkins M, Fry CS, Abramowitz MK. Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis. JCI Insight. 2021 Dec 22;6(24):e150112. doi: 10.1172/jci.insight.150112. PMID: 34784301</p>
</li>
<li>
<p>Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; Symposium planning committee, moderators, and speakers. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Care. 2022 Jan 1;45(1):3-22. doi: 10.2337/dci21-0051. PMID: 34782355</p>
</li>
<li>
<p>Lontchi-Yimagou E, DasGupta R, Kehlenbrink S, Koppaka S, Carey M, Stein DT, Thomas N, Hawkins M. An Atypical form of diabetes in low BMI individuals. Diabetes Care 2022 45(6):1428-1437. doi: 10.2337/dc21-1957. PMID: 35522035 (In the top 5% of all research outputs scored by Altmetric: as of July 13, 2023, the paper has received 8,874 reads and has been picked up by 94 news outlets.)</p>
</li>
<li>
<p>Lontchi-Yimagou E, Anoop S, Kurian ME, Ye K, Kehlenbrink S, Thomas N, Hawkins M. Response to Comment on Lontchi-Yimagou et al. An Atypical Form of Diabetes Among Individuals With Low BMI. Diabetes Care 2022;45:1428-1437. Diabetes Care. 2022 Nov 1;45(11):e159-e160. doi: 10.2337/dci22-0031.PMID: 36318676</p>
</li>
<li>
<p>Herman WH, Schillinger D, Bolen S, Boltri JM, Bullock A, Chong W, Conlin PR, Cook JW, Dokun A, Fukagawa N, Gonzalvo J, Greenlee MC, Hawkins M, Idzik S, Leake E, Linder B, Lopata AM, Schumacher P, Shell D, Strogatz D, Towne J, Tracer H, Wu S. The National Clinical Care Commission Report to Congress: Recommendations to Better Leverage Federal Policies and Programs to Prevent and Control Diabetes. Diabetes Care. 2023 Feb 1;46(2):255-261. doi: 10.2337/dc22-1587. PMID: 36701592</p>
</li>
<li>
<p>Greenlee MC, Bolen S, Chong W, Dokun A, Gonzalvo J, Hawkins M, Herman WH, Leake E, Linder B, Conlin PR. The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Improve Diabetes Treatment and Reduce Complications. Diabetes Care. 2023 Feb 1;46(2):e51-e59. doi: 10.2337/dc22-0621. PMID: 36701593</p>
</li>
<li>
<p>Cook J, Hawkins M, Pajvani UB. Liver insulinization as a driver of triglyceride dysmetabolism. Nature Medicine. 2023 (e-publication 17 July 2023)</p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
</li>
</ol>
Patricia A. Hametz
Dr. Hametz's clinical focus is on providing family-centered care for all hospitalized children and on developing and implementing systems of care for children with medical complexities.
Dr. Hametz’s research focuses on improving care and the systems in which care is provided to hospitalized children and adolescents, and their families.
<p>Patricia A. Hametz, MD, MPH, is Chief of the Division of Pediatric Hospital Medicine at Children’s Hospital at Montefiore Einstein (CHAM). As Chief, she oversees the care of children admitted to the general pediatrics service, consultation service and co-management of patients on the pediatric surgery and surgical subspecialty services. She is also an Attending Physician at CHAM and an Associate Professor of Pediatrics at Albert Einstein College of Medicine. Her clinical focus is on providing family-centered care for all hospitalized children and on developing and implementing systems of care for children with medical complexities.</p><p>Dr. Hametz received her Doctor of Medicine in 1995 from Columbia University College of Physicians and Surgeons in New York. In 2008, she received her Master of Public Health from Columbia University Mailman School of Public Health. Dr. Hametz completed an internship and residency in Pediatrics at Morgan Stanley Children's Hospital of New York from 1995 to 1999 and became Chief Resident in 1998.</p><p>Dr. Hametz’s research focuses on improving care and the systems in which care is provided to hospitalized children and adolescents, and their families. Her original communications have been published in numerous peer-reviewed journals, as well as invited publications. She has been an invited speaker to regional and local presentations.</p><p>Dr. Hametz has been recognized as an outstanding teacher, was nominated for the Attending Teacher of the Year Award several times and also won the Pediatric Residency Appreciation Award in 2015. Dr. Hametz is board certified by the American Board of Pediatrics and is a Resident Member of the American Academy of Pediatrics.</p>
Samuel V. Gorstein
<p>Samuel Gorstein, MD, is Director, Resident Education, Pediatric Intensive Care Unit (PICU) at the Children’s Hospital at Montefiore Einstein (CHAM) and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Gorstein’s clinical focus is on the care of critically ill infants, children and adolescents, focusing on conditions requiring intensive monitoring, life support and complex interventions, such as respiratory failure, sepsis, trauma and post-surgical recovery.
</p><p>After obtaining a Bachelor of Science in Biophysics from Brown University, Dr. Gorstein attended the University of Massachusetts Medical School, where he received his Doctor of Medicine in 2009. He then began his postgraduate training with an internship and residency in Pediatrics at Baystate Medical Center from 2009 to 2012. In 2015, he completed a fellowship in Pediatric Critical Care at Massachusetts General Hospital. </p><p>Dr. Gorstein oversees resident education in the PICU and has developed a didactic curriculum for residents rotating through the PICU at CHAM. His research aligns with his clinical expertise, and his work has been shared through peer-reviewed publications, invited presentations, abstracts, and poster presentations at professional meetings. </p><p>Dr. Gorstein is board-certified in Pediatrics and Pediatric Critical Care Medicine. He is a member of the American Academy of Pediatrics and the Society of Critical Care Medicine.
</p>